| Trial ID: | L6383 |
| Source ID: | NCT00494988
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart|DRUG: insulin NPH
|
| Outcome Measures: |
Primary: Remission rate, after 24 weeks | Secondary: blood glucose profiles|HbA1c
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
33
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-12
|
| Completion Date: |
2006-04
|
| Results First Posted: |
|
| Last Update Posted: |
2016-03-04
|
| Locations: |
Beijing, 100029, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00494988
|
